1. Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
- Author
-
Xu J, Kausalya PJ, Van Hul N, Caldez MJ, Xu S, Ong AGM, Woo WL, Mohamed Ali S, Kaldis P, and Hunziker W
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 11 genetics, ATP Binding Cassette Transporter, Subfamily B, Member 11 metabolism, Animals, Aryl Hydrocarbon Hydroxylases metabolism, Bile Acids and Salts metabolism, Bile Canaliculi pathology, Chemical and Drug Induced Liver Injury drug therapy, Cholagogues and Choleretics therapeutic use, Cholic Acid, Claudin-1 metabolism, Cytochrome P450 Family 2 metabolism, Cytoskeletal Proteins metabolism, Epithelial Cells, Female, Fibrosis, Genetic Predisposition to Disease, Hepatocytes, Male, Membrane Proteins metabolism, Mice, Mice, Knockout, Mutation, Oxazoles therapeutic use, Permeability, Protective Factors, RNA, Messenger metabolism, Steroid Hydroxylases metabolism, Tight Junctions ultrastructure, Ursodeoxycholic Acid therapeutic use, Zonula Occludens-2 Protein deficiency, Bile Canaliculi metabolism, Chemical and Drug Induced Liver Injury genetics, Cholestasis genetics, Tight Junctions metabolism, Zonula Occludens-2 Protein genetics
- Abstract
Background & Aims: Liver tight junctions (TJs) establish tissue barriers that isolate bile from the blood circulation. TJP2/ZO-2-inactivating mutations cause progressive cholestatic liver disease in humans. Because the underlying mechanisms remain elusive, we characterized mice with liver-specific inactivation of Tjp2., Methods: Tjp2 was deleted in hepatocytes, cholangiocytes, or both. Effects on the liver were assessed by biochemical analyses of plasma, liver, and bile and by electron microscopy, histology, and immunostaining. TJ barrier permeability was evaluated using fluorescein isothiocyanate-dextran (4 kDa). Cholic acid (CA) diet was used to assess susceptibility to liver injury., Results: Liver-specific deletion of Tjp2 resulted in lower Cldn1 protein levels, minor changes to the TJ, dilated canaliculi, lower microvilli density, and aberrant radixin and bile salt export pump (BSEP) distribution, without an overt increase in TJ permeability. Hepatic Tjp2-defcient mice presented with mild progressive cholestasis with lower expression levels of bile acid transporter Abcb11/Bsep and detoxification enzyme Cyp2b10. A CA diet tolerated by control mice caused severe cholestasis and liver necrosis in Tjp2-deficient animals. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene ameliorated CA-induced injury by enhancing Cyp2b10 expression, and ursodeoxycholic acid provided partial improvement. Inactivating Tjp2 separately in hepatocytes or cholangiocytes showed only mild CA-induced liver injury., Conclusion: Tjp2 is required for normal cortical distribution of radixin, canalicular volume regulation, and microvilli density. Its inactivation deregulated expression of Cldn1 and key bile acid transporters and detoxification enzymes. The mice provide a novel animal model for cholestatic liver disease caused by TJP2-inactivating mutations in humans., (Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF